Literature DB >> 17110462

Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells.

Marina I Garín1, Chung-Ching Chu, Dela Golshayan, Eva Cernuda-Morollón, Robin Wait, Robert I Lechler.   

Abstract

The naturally occurring population of dedicated regulatory T cells that coexpress CD4 and CD25 is known to play a key role in the maintenance of peripheral T-cell tolerance; however, their mechanism of action has remained obscure. Here we report that a member of the family of beta-galactoside-binding proteins, galectin-1, is overexpressed in regulatory T cells, and that expression is increased after activation. Most importantly, blockade of galectin-1 binding significantly reduced the inhibitory effects of human and mouse CD4+CD25+ T cells. Reduced regulatory activity was observed in CD4+CD25+ T cells obtained from galectin-1-homozygous null mutant mice. These results suggest that galectin-1 is a key effector of the regulation mediated by these cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17110462     DOI: 10.1182/blood-2006-04-016451

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  177 in total

Review 1.  In search of a solution to the sphinx-like riddle of GM1.

Authors:  Robert W Ledeen; Gusheng Wu
Journal:  Neurochem Res       Date:  2010-11-13       Impact factor: 3.996

2.  Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans.

Authors:  Pervinder Sagoo; Esperanza Perucha; Birgit Sawitzki; Stefan Tomiuk; David A Stephens; Patrick Miqueu; Stephanie Chapman; Ligia Craciun; Ruhena Sergeant; Sophie Brouard; Flavia Rovis; Elvira Jimenez; Amany Ballow; Magali Giral; Irene Rebollo-Mesa; Alain Le Moine; Cecile Braudeau; Rachel Hilton; Bernhard Gerstmayer; Katarzyna Bourcier; Adnan Sharif; Magdalena Krajewska; Graham M Lord; Ian Roberts; Michel Goldman; Kathryn J Wood; Kenneth Newell; Vicki Seyfert-Margolis; Anthony N Warrens; Uwe Janssen; Hans-Dieter Volk; Jean-Paul Soulillou; Maria P Hernandez-Fuentes; Robert I Lechler
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

3.  Regulatory T cells and Atherosclerosis.

Authors:  Jahaira Lopez Pastrana; Xiaojin Sha; Anthony Virtue; Jietang Mai; Ramon Cueto; In Ae Lee; Hong Wang; Xiao-Feng Yang
Journal:  J Clin Exp Cardiolog       Date:  2012-10-08

Review 4.  Expanding the universe of cytokines and pattern recognition receptors: galectins and glycans in innate immunity.

Authors:  Juan P Cerliani; Sean R Stowell; Iván D Mascanfroni; Connie M Arthur; Richard D Cummings; Gabriel A Rabinovich
Journal:  J Clin Immunol       Date:  2010-12-24       Impact factor: 8.317

5.  The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma.

Authors:  Przemyslaw Juszczynski; Jing Ouyang; Stefano Monti; Scott J Rodig; Kunihiko Takeyama; Jeremy Abramson; Wen Chen; Jeffery L Kutok; Gabriel A Rabinovich; Margaret A Shipp
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-01       Impact factor: 11.205

6.  MLL-rearranged B lymphoblastic leukemias selectively express the immunoregulatory carbohydrate-binding protein galectin-1.

Authors:  Przemyslaw Juszczynski; Scott J Rodig; Jing Ouyang; Evan O'Donnell; Kunihiko Takeyama; Wojciech Mlynarski; Katarzyna Mycko; Tomasz Szczepanski; Anna Gaworczyk; Andrei Krivtsov; Joerg Faber; Amit U Sinha; Gabriel A Rabinovich; Scott A Armstrong; Jeffery L Kutok; Margaret A Shipp
Journal:  Clin Cancer Res       Date:  2010-03-23       Impact factor: 12.531

Review 7.  Natural regulatory T cells in autoimmunity.

Authors:  Elaine V Lourenço; Antonio La Cava
Journal:  Autoimmunity       Date:  2010-11-23       Impact factor: 2.815

8.  In vitro induction of T cells that are resistant to A2 adenosine receptor-mediated immunosuppression.

Authors:  Akio Ohta; J Kjaergaard; S Sharma; M Mohsin; N Goel; M Madasu; E Fradkov; Akiko Ohta; M Sitkovsky
Journal:  Br J Pharmacol       Date:  2008-12-09       Impact factor: 8.739

9.  Suppression of autoimmune diabetes by soluble galectin-1.

Authors:  Marcelo J Perone; Suzanne Bertera; William J Shufesky; Sherrie J Divito; Angela Montecalvo; Alicia R Mathers; Adriana T Larregina; Mabel Pang; Nilufer Seth; Kai W Wucherpfennig; Massimo Trucco; Linda G Baum; Adrian E Morelli
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

10.  Differential expression of immunomodulatory galectin-1 in peripheral leukocytes and adult tissues and its cytosolic organization in striated muscle.

Authors:  Marcelo Dias-Baruffi; Sean R Stowell; Shuh-Chyung Song; Connie M Arthur; Moonjae Cho; Lilian C Rodrigues; Marlise A B Montes; Marcos A Rossi; Judith A James; Rodger P McEver; Richard D Cummings
Journal:  Glycobiology       Date:  2010-01-05       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.